---
title: "MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer | MAIA Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283009172.md"
description: "MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer | MAIA Stock News"
datetime: "2026-04-16T05:20:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283009172.md)
  - [en](https://longbridge.com/en/news/283009172.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283009172.md)
---

# MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer | MAIA Stock News

MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer | MAIA Stock News

### Related Stocks

- [MAIA.US](https://longbridge.com/en/quote/MAIA.US.md)

## Related News & Research

- [MAIA Biotechnology to Terminate ATM Agreement With H.C. Wainwright After Raising $5.68M](https://longbridge.com/en/news/286468852.md)
- [EXCLUSIVE: Hoth Therapeutics To Rebrand To Pursue AI Chip Technologies](https://longbridge.com/en/news/286908929.md)
- [MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial](https://longbridge.com/en/news/282051269.md)
- [21:15 ETAutonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work](https://longbridge.com/en/news/286985056.md)
- [13:01 ETGrowth Catalyst Group Appoints Maia Benson as Chief Commercial Officer](https://longbridge.com/en/news/286596195.md)